Nuvectis Pharma Directors Make Significant Share Purchases at $5.72-$5.84/Share

Nuvectis Pharma, Inc. (NVCT) has announced that Director and 10% owner BENTSUR RON has acquired 5,000 shares at a price of $5.72 per share on November 5, 2025. Additionally, Director Kaplan Matthew L. has purchased 11,000 shares at a price of $5.84 per share on the same date, while Director Sanchez Juan has acquired 13,000 shares at a price of $5.79 per share on November 5, 2025.